VOLITIONRX LTD — Director's Dealing 2020

Dec 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-12-22

Reporting Person: Vanston David Cecil (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-22	Stock Option (Right to Buy)	$4	G	60000	Disposed	2024-01-23	Common Stock (60000)	Direct
2020-12-22	Stock Option (Right to Buy)	$4	G	60000	Acquired	2024-01-23	Common Stock (60000)	Indirect
2020-12-22	Stock Option (Right to Buy)	$3.25	G	50000	Disposed	2025-02-11	Common Stock (50000)	Direct
2020-12-22	Stock Option (Right to Buy)	$3.25	G	50000	Acquired	2025-02-11	Common Stock (50000)	Indirect

Footnotes

F1: The option to purchase an aggregate of 60,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Mr. Vanston on January 23, 2018, under the Issuer's 2015 Stock Incentive Plan (the "2015 Plan"). The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter.

F2: The option to purchase an aggregate of 50,000 shares of Common Stock of the Issuer was granted to Mr. Vanston on February 11, 2019 under the Issuer's 2015 Plan. The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter.